Changzhou Tongtai Biopharmaceutical Co., Ltd. is being launched with the goal of producing inactivated rabies animal vaccines. Presently, China veterinarians have to choose between a less-effective, domestically produced, attenuated rabies inactivated vaccine and a more expensive imported vaccine. Changzhou Tongtai expects to be the first company in China with a domestically produced inactivated rabies vaccine, offering safety and efficacy at a low cost. The effort is under the supervision of a team of overseas scientists, headed by Dr. Fu Zhenfang, Professor of Veterinary Pathology at the College of Veterinary Medicine, the University of Georgia. More details...